In2sight joins 3Rs intiative in europe

In2Sight seeks to advance the creation ethically sustainable bio-tests by introducing a revolutionary in-vivo optical imaging tool with the potential to quantify and analyze the host’s inflammatory response to implants. Form 2022, with distinguished partners from five countries, In2Sight is also part of the Cost Action IMPROVE (CA21139), a pan-European research infrastructure dedicated to expediting the translation of cutting-edge optical imaging tools from the laboratory to clinical practice, and of the 3R Italian center.

Leave A Comment

Your email address will not be published. Required fields are marked *

Archives

Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback